United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-857_ffd82a69-a64c-4399-8f5d-bddc70cdc3cf
- Product NDC
- 71205-857
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190301
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-00) · 71205-857-00
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-11) · 71205-857-11
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-30) · 71205-857-30
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-55) · 71205-857-55
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-60) · 71205-857-60
- 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-72) · 71205-857-72
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71205-857-90) · 71205-857-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →